Vergleich mehrerer Laborproben (Symbolbild).
Montag, 27.04.2020 22:00 von | Aufrufe: 82

CVS Health to Significantly Expand COVID-19 Testing Capabilities

Vergleich mehrerer Laborproben (Symbolbild). pixabay.com

PR Newswire

WOONSOCKET, R.I., April 27, 2020 /PRNewswire/ -- CVS Health (NYSE: CVS) will join other pharmacy chains and retailers at the White House today to announce the next phase in COVID-19 testing. In addition to the large-scale test sites the company has been operating since March, CVS Health will utilize its expansive community presence to bring testing closer to home while maintaining strict safety standards.

"Our industry has been united by the unique role we can play in addressing the pandemic and protecting people's health," said Larry J. Merlo, President and CEO, CVS Health. "We all share the same goal, and that's dramatically increasing the frequency and efficiency of testing so we can slow the spread of the virus and start to responsibly reopen the economy when experts tell us it's safe."

Beginning in May, CVS Health will offer self-swab tests to individuals meeting Centers for Disease Control and Prevention criteria. Testing will be scheduled online and take place at select CVS Pharmacy locations in parking lots or at drive-thru windows; no testing will take place in-store. Employees participating in the test collection process will maintain safety using personal protective equipment and follow sanitization protocols after each test. The company expects to have up to 1,000 locations across the country offering this service by the end of May, with the goal of processing up to 1.5 million tests per month subject to availability of supplies and lab capacity.

CVS Health's COVID-19 testing strategy is driven by science, but also by the reality that minorities have been disproportionately impacted by the virus. The company has partnered with several organizations, including the National Medical Association, to improve access to testing and necessary care for historically underserved communities. CVS Health is also developing mobile solutions that will allow health care professionals to bring testing capabilities to these communities, and those same services can be utilized for businesses that will begin to re-open in the coming weeks and months.

CVS Health currently operates large-scale COVID-19 rapid test sites in five states, which were opened in a matter of weeks through partnerships with the Department of Health and Human Services and governors in Connecticut, Georgia, Massachusetts, Michigan and Rhode Island. Most of the parking lot sites can accommodate up to 1,000 tests per day, and sites are overseen by licensed health care providers from MinuteClinic, the retail medical clinic inside CVS Pharmacy locations, with assistance from CVS pharmacists and other employees.

"The selflessness displayed every day by the health care professionals at CVS Health and around the world is inspiring beyond words, and we owe them a debt of gratitude," Merlo continued. "The same is true for frontline workers everywhere who continue to provide essential goods and services when we need them most."


ARIVA.DE Börsen-Geflüster

Werbung

Weiter abwärts?

Kurzfristig positionieren in CVS Health Corp.
VU8J06
Ask: 2,16
Hebel: 6,44
mit moderatem Hebel
Zum Produkt
Smartbroker
Vontobel
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: VU8J06,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.

Kurse

60,22 $
-1,33%
CVS Health Corp. Chart

More information on steps CVS Health has taken to address the COVID-19 pandemic, including support for health care providers and clinicians facing financial and administrative strain, is available at the company's frequently updated COVID-19 resource center.

Contact: T.J. Crawford, crawfordt2@aetna.com, 212-457-0583

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cvs-health-to-significantly-expand-covid-19-testing-capabilities-301047739.html

SOURCE CVS Health

Werbung

Mehr Nachrichten zur CVS Health Corp. Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News